OptimizeRx
OPRX
#8990
Rank
HK$0.97 B
Marketcap
HK$51.89
Share price
1.38%
Change (1 day)
-19.25%
Change (1 year)

Earnings for OptimizeRx (OPRX)

Earnings in 2025 (TTM): HK$56.99 Million

According to OptimizeRx's latest financial reports the company's current earnings are HK$0.10 Billion. In 2024 the company made an earning of -HK$0.11 Billion, an increase over its 2023 earnings that were of -HK$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for OptimizeRx from 2008 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$56.99 M-154.99%
2024 -HK$0.11 Billion-38.79%
2023 -HK$0.17 Billion75.76%
2022 -HK$96.34 Million-3503.68%
2021 HK$2.83 M-116.91%
2020 -HK$16.74 Million-36.13%
2019 -HK$26.21 Million-515.42%
2018 HK$6.3 M-138.25%
2017 -HK$16.5 Million36.7%
2016 -HK$12.07 Million159.05%
2015 -HK$4.66 Million-49.7%
2014 -HK$9.26 Million280.42%
2013 -HK$2.44 Million-14.74%
2012 -HK$2.86 Million-76.84%
2011 -HK$12.33 Million-17.37%
2010 -HK$14.92 Million
2008 -HK$33.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Park City Group
PCYG
HK$47.71 M-16.63%๐Ÿ‡บ๐Ÿ‡ธ USA
LivePerson
LPSN
-HK$0.47 Billion-904.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Brightcove
BCOV
-HK$62.96 Million-209.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Crexendo
CXDO
HK$36.33 M-36.52%๐Ÿ‡บ๐Ÿ‡ธ USA